Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring Shuiniujiao Dihuang Decoction with variation for treating psoriasis vulgaris has an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shuiniujiao Dihuang Decoction with Variation

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Psoriasis Vulgaris | Phase 2 | Status: UNKNOWN